113 related articles for article (PubMed ID: 32914001)
1. Case of Basal Cell Carcinoma of the Prostate Successfully Treated Before and After a
Grossman JE; Wu Y; Ye H; Bhatt RS
JCO Precis Oncol; 2018; 2():. PubMed ID: 32914001
[No Abstract] [Full Text] [Related]
2. Diverse
Weigelt B; Comino-Méndez I; de Bruijn I; Tian L; Meisel JL; García-Murillas I; Fribbens C; Cutts R; Martelotto LG; Ng CKY; Lim RS; Selenica P; Piscuoglio S; Aghajanian C; Norton L; Murali R; Hyman DM; Borsu L; Arcila ME; Konner J; Reis-Filho JS; Greenberg RA; Robson ME; Turner NC
Clin Cancer Res; 2017 Nov; 23(21):6708-6720. PubMed ID: 28765325
[No Abstract] [Full Text] [Related]
3. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer.
Singer CF; Rappaport-Fuerhauser C; Sopik V; Narod SA
Clin Genet; 2015 Aug; 88(2):187-9. PubMed ID: 25112434
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer progression and survival in BRCA2 mutation carriers.
Tryggvadóttir L; Vidarsdóttir L; Thorgeirsson T; Jonasson JG; Olafsdóttir EJ; Olafsdóttir GH; Rafnar T; Thorlacius S; Jonsson E; Eyfjord JE; Tulinius H
J Natl Cancer Inst; 2007 Jun; 99(12):929-35. PubMed ID: 17565157
[TBL] [Abstract][Full Text] [Related]
6. The influence of BRCA2 mutation on localized prostate cancer.
Taylor RA; Fraser M; Rebello RJ; Boutros PC; Murphy DG; Bristow RG; Risbridger GP
Nat Rev Urol; 2019 May; 16(5):281-290. PubMed ID: 30808988
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.
Roed Nielsen H; Petersen J; Therkildsen C; Skytte AB; Nilbert M
Acta Oncol; 2016; 55(1):38-44. PubMed ID: 26360800
[TBL] [Abstract][Full Text] [Related]
8. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
9. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
Lehrer S; Fodor F; Stock RG; Stone NN; Eng C; Song HK; McGovern M
Br J Cancer; 1998 Sep; 78(6):771-3. PubMed ID: 9743298
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 mutation in Icelandic prostate cancer patients.
Sigurdsson S; Thorlacius S; Tomasson J; Tryggvadottir L; Benediktsdottir K; Eyfjörd JE; Jonsson E
J Mol Med (Berl); 1997 Oct; 75(10):758-61. PubMed ID: 9383000
[TBL] [Abstract][Full Text] [Related]
11. Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Thorne H; Willems AJ; Niedermayr E; Hoh IM; Li J; Clouston D; Mitchell G; Fox S; Hopper JL; ; Bolton D
Cancer Prev Res (Phila); 2011 Jul; 4(7):1002-10. PubMed ID: 21733824
[TBL] [Abstract][Full Text] [Related]
12. Acquired multiple secondary
Tao H; Liu S; Huang D; Han X; Wu X; Shao YW; Hu Y
Am J Transl Res; 2020; 12(2):612-617. PubMed ID: 32194909
[TBL] [Abstract][Full Text] [Related]
13. BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Kirchhoff T; Kauff ND; Mitra N; Nafa K; Huang H; Palmer C; Gulati T; Wadsworth E; Donat S; Robson ME; Ellis NA; Offit K
Clin Cancer Res; 2004 May; 10(9):2918-21. PubMed ID: 15131025
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.
Willems AJ; Dawson SJ; Samaratunga H; De Luca A; Antill YC; Hopper JL; Thorne HJ;
Clin Cancer Res; 2008 May; 14(10):2953-61. PubMed ID: 18445692
[TBL] [Abstract][Full Text] [Related]
15. The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
Jenzer M; Keß P; Nientiedt C; Endris V; Kippenberger M; Leichsenring J; Stögbauer F; Haimes J; Mishkin S; Kudlow B; Kaczorowski A; Zschäbitz S; Volckmar AL; Sültmann H; Jäger D; Duensing A; Schirmacher P; Hohenfellner M; Grüllich C; Stenzinger A; Duensing S
Cancer Immunol Immunother; 2019 Oct; 68(10):1621-1633. PubMed ID: 31549213
[TBL] [Abstract][Full Text] [Related]
16. Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.
van der Groep P; van Diest PJ; Menko FH; Bart J; de Vries EG; van der Wall E
J Clin Pathol; 2009 Oct; 62(10):926-30. PubMed ID: 19541683
[TBL] [Abstract][Full Text] [Related]
17. Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
Kuang S; Li H; Feng J; Xu S; Le Y
Cancer Biomark; 2019; 25(2):203-212. PubMed ID: 31045513
[TBL] [Abstract][Full Text] [Related]
18. A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation.
Kosaka T; Hongo H; Aimono E; Matsumoto K; Hayashida T; Mikami S; Nishihara H; Oya M
Pathol Int; 2019 Dec; 69(12):715-720. PubMed ID: 31631483
[TBL] [Abstract][Full Text] [Related]
19. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Oh M; Alkhushaym N; Fallatah S; Althagafi A; Aljadeed R; Alsowaida Y; Jeter J; Martin JR; Babiker HM; McBride A; Abraham I
Prostate; 2019 Jun; 79(8):880-895. PubMed ID: 30900310
[TBL] [Abstract][Full Text] [Related]
20. BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer.
Cui M; Gao XS; Gu X; Guo W; Li X; Ma M; Qin S; Qi X; Xie M; Peng C; Bai Y
Oncotarget; 2017 Jun; 8(25):40222-40232. PubMed ID: 28410213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]